ArticleBMC cardiovascular disorders2025
Association of the single-nucleotide polymorphism in the MFG-E8 gene with coronary heart disease in Chinese Han population.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Coronary atherosclerosis narrows or occludes blood vessels, resulting in myocardial ischemia and hypoxia, which ultimately leads to coronary heart disease (CHD). The pathogenesis of CHD remains insufficiently elucidated. A widely accepted hypothesis is that various stimuli induce arterial intima injury, and atherosclerosis (AS)formation reflects the inflammatory-fibroproliferative response of the intima to such injury. Milk fat globule epidermal growth factor 8 (MFG-E8) is expressed in cells implicated in CHD development, including macrophages, endothelial cells, and vascular smooth muscle cells, suggestion it play a regulatory role in multiple key stages of AS progression (such as foam cell formation and plaque instability). However, theassociation between MFG-E8 gene polymorphisms and CHD susceptibility in humans remains unclear. This study aimed to investigate the relationship between serum MFG-E8 levels, MFG-E8 single nucleotide polymorphisms (SNPs), and CHD. Additionally, We genotyped tag SNPs to provide insights for future screening of high-risk CHD populations and the identification of novel therapeutic targets.The serum MFG-E8 concentration was significantly lower in the CHD group(n = 158) than in the control group (n = 183) (P < 0.001). The rs1878326 polymorphism showed no statistically significant association with CHD susceptibility (P > 0.05). The rs4945† (C > A, reverse complement equivalent to NCBI G > T) polymorphism in the MFG-E8 gene was associated with an increased risk of CHD (CA genotype vs.CC genotype: OR = 2.029, 95% CI: 1.229-3.349, P = 0.006; A allele vs. C allele: OR = 1.835, 95% CI: 1.153-2.921, P = 0.010). However, the rs4945 polymorphism did not significantly influence serum MFG-E8 levels. Our findings suggest that the CA genotype and A allele of the MFG-E8 rs4945 polymorphism are associated with an elevated CHD risk in a Chinese Han population. However, due to the limited sample size of the study, further studies are needed to validate these associations between MFG-E8 gene polymorphisms and CHD susceptibility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.